Key facts
- This page summarizes Donald P. Lehr's Form 4 filing for PRECIGEN, INC. (PGEN).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 22 Apr 2026, 16:23.
Donald P. Lehr - 20 Apr 2026 Form 4 Insider Report for PRECIGEN, INC. (PGEN)
- Reporting relationship
- Chief Legal Officer
- Issuer ticker
- PGEN
- Reported as of
- 20 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Apr 2026, 16:23:37 UTC
- Prior SEC filing
- 20 Mar 2026
- Next SEC filing
- 27 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Donald P. Lehr
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Donald P. Lehr filed Form 4 for PRECIGEN, INC. (PGEN) on 22 Apr 2026.
Change
- Previous filing in this sequence was filed on 20 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001583187
Primary reporting owner
Lehr Donald P.
- Relationship
- Chief Legal Officer
- Address
- 20374 SENECA MEADOWS PARKWAY, GERMANTOWN
- Signature
- /s/ Donald P. Lehr
- Signature date
- 22 Apr 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PGEN
transaction
Derivative
Option to Purchase Common Stock (Right to Buy)
Award
- Transaction value
- Shares
- +358,000
- Change %
- Price
- $0.000000*
- Shares after
- 358,000
- Date
- 20 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 358,000
- Exercise price
- $4.11
- Footnotes
- F1
PGEN
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- Shares
- +107,000
- Change %
- Price
- $0.000000*
- Shares after
- 107,000
- Date
- 20 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 107,000
- Exercise price
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The options vest 25% on May 23, 2027 and in equal monthly installments for three years thereafter.
Footnote F2
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
Footnote F3
The RSUs vest 25% on May 23, 2027 and in equal six-month installments for three years thereafter.